Thu, May 30, 2019
Wed, May 29, 2019
Tue, May 28, 2019
Fri, May 24, 2019
Thu, May 23, 2019
Wed, May 22, 2019

Kevin Caliendo Downgraded (TEVA) to Hold and Decreased Target to $12 on, May 28th, 2019

Kevin Caliendo of UBS, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $22 to $12 on, May 28th, 2019.

Kevin has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $17 on, Thursday, May 9th, 2019
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $17 on, Wednesday, March 6th, 2019
  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019


These are the ratings of the 2 analyists that currently disagree with Kevin


  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Decreased Target to $23 on, Thursday, April 11th, 2019
  • Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019